Abstract
Nucleic acid aptamers, generated by an in vitro selection procedure named SELEX (Systematic Evolution of Ligands by EXponential enrichment), have been popularly used in various biomedical implementations so far. An adaptation of the conventional SELEX practice to whole living cells was referred to as cell-SELEX, which is very promising in ample sophisticated analytical, therapeutic and diagnostic applications. The current review article would like to provide a survey of contemporary developments in cell-specific aptamers, including methodology, applications and optimization of cell-SELEX.
Keywords: Cell-SELEX, aptamer, therapeutics, diagnostics, nucleic acids, nutrition during the first months, Scientific Committee on Food, iron fortification, infant formula higher, cow's milk protein, protein hydrolysates, ESPGHAN, Child Nutrition, Diet Committee, IRON IN CF, bioavailable, Advances and Perspectives in Cell-Specific Aptamers, non-heme iron, complementary food
Current Pharmaceutical Design
Title: Advances and Perspectives in Cell-Specific Aptamers
Volume: 17 Issue: 1
Author(s): Wei Sun, Lupei Du and Minyong Li
Affiliation:
Keywords: Cell-SELEX, aptamer, therapeutics, diagnostics, nucleic acids, nutrition during the first months, Scientific Committee on Food, iron fortification, infant formula higher, cow's milk protein, protein hydrolysates, ESPGHAN, Child Nutrition, Diet Committee, IRON IN CF, bioavailable, Advances and Perspectives in Cell-Specific Aptamers, non-heme iron, complementary food
Abstract: Nucleic acid aptamers, generated by an in vitro selection procedure named SELEX (Systematic Evolution of Ligands by EXponential enrichment), have been popularly used in various biomedical implementations so far. An adaptation of the conventional SELEX practice to whole living cells was referred to as cell-SELEX, which is very promising in ample sophisticated analytical, therapeutic and diagnostic applications. The current review article would like to provide a survey of contemporary developments in cell-specific aptamers, including methodology, applications and optimization of cell-SELEX.
Export Options
About this article
Cite this article as:
Sun Wei, Du Lupei and Li Minyong, Advances and Perspectives in Cell-Specific Aptamers, Current Pharmaceutical Design 2011; 17 (1) . https://dx.doi.org/10.2174/138161211795049769
DOI https://dx.doi.org/10.2174/138161211795049769 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
Current Molecular Medicine Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy
Current Pharmaceutical Design Promising Targets in Anti-cancer Drug Development: Recent Updates
Current Medicinal Chemistry Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
Current Medicinal Chemistry Defining Viral Protein Interactomes Using the Yeast Two-Hybrid Assay
Current Proteomics Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Editorial
Current Medical Imaging Pharmacology and Therapeutic Applications of Enediyne Antitumor Antibiotics
Current Molecular Pharmacology Chemical Advances in Therapeutic Application of Exosomes and Liposomes
Current Medicinal Chemistry Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer
Current Drug Delivery Viral Vector-Mediated Gene Therapy for Hemophilia
Current Gene Therapy RETRACTED: Novel and safer self-inactivating vectors for gene therapy of Wiskott-Aldrich Syndrome
Current Gene Therapy Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease
Current Alzheimer Research Doxorubicin vs. ladirubicin: methods for improving osteosarcoma treatment
Mini-Reviews in Medicinal Chemistry CD248: Reviewing its Role in Health and Disease
Current Drug Targets Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds
Current Medicinal Chemistry - Anti-Cancer Agents MATra - Magnet Assisted Transfection: Combining Nanotechnology and Magnetic Forces to Improve Intracellular Delivery of Nucleic Acids
Current Pharmaceutical Biotechnology Development of Genetic Testing for Breast, Ovarian and Colorectal Cancer Predisposition: A Step Closer to Targeted Cancer Prevention
Current Drug Targets